Tatva Chintan Q4 Results Review - Revenue May Rise 25% With Expansion In Margin: ICICI Securities
2 months ago•Bloomberg Quint
Tatva Chintan - Delay In EU 7 Implementation Poses Risk To SDA Growth: Nirmal Bang
4 months ago•Bloomberg Quint
Accumulate Tatva Chintan Pharma Chem; target of Rs 1487: KR Choksey
6 months ago•Moneycontrol
Tatva Chintan gains after fixing floor price of Rs 1704.74 a share for QIP
11 months ago•Moneycontrol
Key Stocks In Focus: Paytm, Amber Enterprises, Tatva Chintan Pharma, Aurobindo Pharma, GIC RE, BEL
11 months ago•CNBC-TV18
Stocks To Trade | Tatva Chintan और Hindustan Aeronautics को Portfolio में जोड़ने का फायदा?
11 months ago•CNBC Awaaz.
IdeaForge lists at 94% above its IPO price
1 year ago•Economic Times